{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T12:27:54Z","timestamp":1786969674391,"version":"build-2736575974"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9]]},"abstract":"Abstract<\/jats:title>\n \n Background:<\/jats:title>\n Prostate cancer is the second most commonly diagnosed cancer in men worldwide. There has been a stage migration among the population with PCa in developed countries since the introduction of the tumor marker, prostate-specific antigen. It has also been found that patients respond differently to androgen deprivation therapy. A large proportion of PCa arises from androgen-dependent secretory epithelial cells.<\/jats:p>\n <\/jats:sec>\n \n Objectives:<\/jats:title>\n This study quantified prostatic androgen receptor (AR) expression in men with prostate cancer (PCa) and evaluated the possible association of the AR expression with various prognostic parameters in patients with PCa.<\/jats:p>\n <\/jats:sec>\n \n Materials and Methods:<\/jats:title>\n \n This study is a cross-sectional, observational and prospective hospital-based study of patients diagnosed with PCa. All the study participants had clinical evaluation, serum prostate-specific antigen (PSA) and a prostate biopsy for histological confirmation and staging. The histologically proven adenocarcinoma specimens were subjected to immunohistochemistry for AR status. Data analysis was performed using SPSS\n (R)<\/jats:sup>\n version 22. AR expression and its relationship to the clinical and histological stages were analysed using the paired\n t<\/jats:italic>\n -test, Chi-squared test and Pearson\u2019s correlation as appropriate. Significance level (\n P<\/jats:italic>\n -value) was set at 0.05.\n <\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n \n Fifty men (aged 38\u201387 years) were enrolled in the study. Thirty-three (64.0%) patients had positive immunoreactivity with a median intensity of 30.00%. There were a significant association between the AR expression and the serum PSA and a weak positive correlation between AR intensity and PSA (both\n P-<\/jats:italic>\n values were 0.025). There was also a significant correlation between the intensity of AR expression and the clinical stage (\n P<\/jats:italic>\n = 0.038); however, no correlation was observed between the AR expression and the Gleason score.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion:<\/jats:title>\n The expression of ARs in men with PCa in our study was 66%, and this showed a correlation with PSA levels. A positive correlation was observed between the intensity of AR expression, PSA and clinical stage. Pre-treatment determination of prostatic AR expression exhibits potential for clinical application as a prognostic biomarker.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/npmj.npmj_32_26","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T04:00:17Z","timestamp":1786939217000},"page":"623-629","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Prostatic Androgen Receptor Expression in Men with Prostate Cancer"],"prefix":"10.4103","volume":"33","author":[{"given":"Emmanuel Abayomi","family":"Animashaun","sequence":"first","affiliation":[{"name":"Department of Surgery, College of Medicine University of Lagos\/Lagos University Teaching Hospital, Idi-Araba, Surulere, Lagos, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rufus Wale","family":"Ojewola","sequence":"additional","affiliation":[{"name":"Department of Surgery, College of Medicine University of Lagos\/Lagos University Teaching Hospital, Idi-Araba, Surulere, Lagos, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odubanjo Mosebolatan","family":"Olatokunboh","sequence":"additional","affiliation":[{"name":"Department of Anatomic and Molecular Pathology, College of Medicine University of Lagos\/Lagos University Teaching Hospital, Idi-Araba, Surulere, Lagos, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moses Adebisi","family":"Ogunjimi","sequence":"additional","affiliation":[{"name":"Department of Surgery, College of Medicine University of Lagos\/Lagos University Teaching Hospital, Idi-Araba, Surulere, Lagos, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel Ajibola","family":"Jeje","sequence":"additional","affiliation":[{"name":"Department of Surgery, College of Medicine University of Lagos\/Lagos University Teaching Hospital, Idi-Araba, Surulere, Lagos, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kehinde Habeeb","family":"Tijani","sequence":"additional","affiliation":[{"name":"Department of Surgery, College of Medicine University of Lagos\/Lagos University Teaching Hospital, Idi-Araba, Surulere, Lagos, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles Chidozie","family":"Anunobi","sequence":"additional","affiliation":[{"name":"Department of Anatomic and Molecular Pathology, College of Medicine University of Lagos\/Lagos University Teaching Hospital, Idi-Araba, Surulere, Lagos, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"key":"R1-20260817","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R2-20260817","doi-asserted-by":"crossref","first-page":"e271","DOI":"10.1016\/j.canep.2012.04.007","article-title":"Cancer incidence in Nigeria: A report from population-based cancer registries","volume":"36","author":"Jedy-Agba","year":"2012","journal-title":"Cancer Epidemiol"},{"key":"R3-20260817","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/S0022-5347(01)64966-8","article-title":"Prostate cancer in Nigerians: Facts and nonfacts","volume":"157","author":"Osegbe","year":"1997","journal-title":"J Urol"},{"key":"R4-20260817","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.urology.2010.03.020","article-title":"Burden of prostate cancer in Southwestern Nigeria","volume":"76","author":"Badmus","year":"2010","journal-title":"Urology"},{"key":"R5-20260817","doi-asserted-by":"crossref","first-page":"129","DOI":"10.11604\/pamj.2013.15.129.2489","article-title":"Prevalence and characteristics of prostate cancer among participants of a community-based screening in Nigeria using serum prostate specific antigen and digital rectal examination","volume":"15","author":"Ikuerowo","year":"2013","journal-title":"Pan Afr Med J"},{"key":"R6-20260817","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1001\/jama.1993.03510080052031","article-title":"Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening","volume":"270","author":"Catalona","year":"1993","journal-title":"JAMA"},{"key":"R7-20260817","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1002\/cncr.33818","article-title":"Presentation, patterns of care, and outcomes of patients with prostate cancer in Sub-Saharan Africa: A population-based registry study","volume":"127","author":"Seraphin","year":"2021","journal-title":"Cancer"},{"key":"R8-20260817","doi-asserted-by":"crossref","first-page":"113","DOI":"10.4103\/1596-3519.68353","article-title":"An overview of cancer of the prostate diagnosis and management in Nigeria: The experience in a Nigerian tertiary hospital","volume":"9","author":"Ajape","year":"2010","journal-title":"Ann Afr Med"},{"key":"R9-20260817","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1097\/00000478-200407000-00013","article-title":"High level of androgen receptor is associated with aggressive clinicopathologic features and decreased biochemical recurrence-free survival in prostate: Cancer patients treated with radical prostatectomy","volume":"28","author":"Li","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R10-20260817","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/j.juro.2010.01.015","article-title":"Evidence supports a faster growth rate and\/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity","volume":"183","author":"Powell","year":"2010","journal-title":"J Urol"},{"key":"R11-20260817","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3934\/molsci.2016.2.280","article-title":"Androgen receptor and prostate cancer","volume":"3","author":"Livermore","year":"2016","journal-title":"AIMS Mol Sci"},{"key":"R12-20260817","doi-asserted-by":"crossref","first-page":"101","DOI":"10.14744\/ijmb.2024.93585","article-title":"Unveiling the latest insights into Androgen receptors in prostate cancer","volume":"7","author":"Zakari","year":"2024","journal-title":"Int J Med Biochem"},{"key":"R13-20260817","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3390\/biom11040492","article-title":"Current status and future perspectives of androgen receptor inhibition therapy for prostate cancer: A comprehensive review","volume":"11","author":"Kim","year":"2021","journal-title":"Biomolecules"},{"key":"R14-20260817","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.eururo.2016.02.028","article-title":"The 2016 WHO classification of tumours of the urinary system and male genital organs-part B: Prostate and bladder tumours","volume":"70","author":"Humphrey","year":"2016","journal-title":"Eur Urol"},{"key":"R15-20260817","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/BF02303615","article-title":"Immunocytochemical assay for androgen receptors in prostate cancer: A prospective study of 63 cases with long-term follow-up","volume":"1","author":"Pertschuk","year":"1994","journal-title":"Ann Surg Oncol"},{"key":"R16-20260817","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/pros.20014","article-title":"Androgen receptor protein expression in prostatic tissues in black and Caucasian men","volume":"59","author":"Olapade-Olaopa","year":"2004","journal-title":"Prostate"},{"key":"R17-20260817","doi-asserted-by":"crossref","first-page":"98","DOI":"10.4103\/1117-1936.170330","article-title":"Prostate diseases in Lagos, Nigeria: A histologic study with tPSA correlation","volume":"18","author":"Anunobi","year":"2011","journal-title":"Niger Postgrad Med J"},{"key":"R18-20260817","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4314\/njsr.v4i1.12167","article-title":"Prostate cancer in Port Harcourt, Nigeria: Features and outcome","volume":"4","author":"Eke","year":"2002","journal-title":"Niger J Surg Res"},{"key":"R19-20260817","first-page":"159","article-title":"Increased incidence of prostate cancer in Nigerians","volume":"91","author":"Ogunbiyi","year":"1999","journal-title":"J Natl Med Assoc"},{"key":"R20-20260817","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/pros.21259","article-title":"Androgen receptors are differentially expressed in Gleason patterns of prostate cancer and down-regulated in matched lymph node metastases","volume":"71","author":"Fleischmann","year":"2011","journal-title":"Prostate"},{"key":"R22-20260817","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"R23-20260817","first-page":"782","article-title":"Current status of prostate cancer in North American black males","volume":"82","author":"Mebane","year":"1990","journal-title":"J Natl Med Assoc"},{"key":"R24-20260817","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/sj.pcan.4500936","article-title":"Androgen receptor and prostate cancer","volume":"10","author":"Richter","year":"2007","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"R25-20260817","first-page":"889","article-title":"Androgen and glucocorticoid receptors in the stroma and epithelium of prostatic hyperplasia and carcinoma","volume":"2","author":"Mohler","year":"1996","journal-title":"Clin Cancer Res"},{"key":"R26-20260817","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1002\/1097-0142(19860615)57:12<2351::AID-CNCR2820571219>3.0.CO;2-F","article-title":"Androgen receptors in cancer of the prostate. Correlation with the stage and grade of the tumor","volume":"57","author":"Habib","year":"1986","journal-title":"Cancer"},{"key":"R27-20260817","first-page":"423","article-title":"Altered expression of androgen receptor in the malignant epithelium and adjacent stroma is associated with early relapse in prostate cancer","volume":"61","author":"Henshall","year":"2001","journal-title":"Cancer Res"},{"key":"R28-20260817","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1001\/archsurg.1941.01210140043004","article-title":"Studies on prostatic cancer: II. The effects of castration on advanced carcinoma of the prostate gland","volume":"43","author":"Huggins","year":"1941","journal-title":"Arch Surg"},{"key":"R29-20260817","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/S0022-5347(17)37389-5","article-title":"Nuclear localization of androgen receptor in heterogeneous samples of normal, hyperplastic and neoplastic human prostate","volume":"147","author":"Chodak","year":"1992","journal-title":"J Urol"},{"key":"R30-20260817","first-page":"735","article-title":"Androgen receptor status in localized and locally progressive hormone refractory human prostate cancer","volume":"144","author":"Ruizeveld de Winter","year":"1994","journal-title":"Am J Pathol"},{"key":"R31-20260817","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/(SICI)1097-0320(19990101)35:1<2::AID-CYTO2>3.0.CO;2-Y","article-title":"Immunohistochemical quantitation of androgen receptor expression using color video image analysis","volume":"35","author":"Kim","year":"1999","journal-title":"Cytometry"},{"key":"R32-20260817","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S0022-5347(17)50585-6","article-title":"The use of multiple variables to predict response to endocrine therapy in carcinoma of the prostate: A preliminary report","volume":"131","author":"Brendler","year":"1984","journal-title":"J Urol"}],"container-title":["Nigerian Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/npmj.npmj_32_26","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T12:02:11Z","timestamp":1786968131000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/npmj.npmj_32_26"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,17]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/npmj.npmj_32_26","relation":{},"ISSN":["1117-1936","2468-6875"],"issn-type":[{"value":"1117-1936","type":"print"},{"value":"2468-6875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,17]]},"assertion":[{"value":"2026-01-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}